Anesthesiology and Pain Medicine

Published by: Kowsar

Treatment of Failed Back Surgery Syndrome in a Forty-Three-Year-Old Man With High-Dose Oxycodone/Naloxone

Borja Mugabure Bujedo 1 , 2 , *
Author Information
1 Department of Anesthesiology, Critical Care and Pain Medicine, Donostia University Hospital, San Sebastian, Spain
2 Pain Relief Unit, Chronic Pain Management, Donostia University Hospital, San Sebastian, Spain
Article information
  • Anesthesiology and Pain Medicine: April 30, 2015, 5 (2); e21009
  • Published Online: April 20, 2015
  • Article Type: Case Report
  • Received: June 8, 2014
  • Revised: August 13, 2014
  • Accepted: September 20, 2014
  • DOI: 10.5812/aapm.21009

To Cite: Bujedo B M. Treatment of Failed Back Surgery Syndrome in a Forty-Three-Year-Old Man With High-Dose Oxycodone/Naloxone, Anesth Pain Med. 2015 ; 5(2):e21009. doi: 10.5812/aapm.21009.

Abstract
Copyright © 2015, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Acknowledgements
Footnote
References
  • 1. Thompson S. Definition, epidemiology and demographics: Failed back surgery syndrome. Br J Pain. 2013; 7(1): 56-9[DOI]
  • 2. Fritsch EW, Heisel J, Rupp S. The failed back surgery syndrome: reasons, intraoperative findings, and long-term results: a report of 182 operative treatments. Spine (Phila Pa 1976). 1996; 21(5): 626-33[PubMed]
  • 3. DePalma MJ, Ketchum JM, Saullo TR. Etiology of chronic low back pain in patients having undergone lumbar fusion. Pain Med. 2011; 12(5): 732-9[DOI][PubMed]
  • 4. Lee PB, Kim YC, Lim YJ, Lee CJ, Choi SS, Park SH, et al. Efficacy of pulsed electromagnetic therapy for chronic lower back pain: a randomized, double-blind, placebo-controlled study. J Int Med Res. 2006; 34(2): 160-7[PubMed]
  • 5. Shapiro CM. The failed back surgery syndrome: pitfalls surrounding evaluation and treatment. Phys Med Rehabil Clin N Am. 2014; 25(2): 319-40[DOI][PubMed]
  • 6. Frey ME, Manchikanti L, Benyamin RM, Schultz DM, Smith HS, Cohen SP. Spinal cord stimulation for patients with failed back surgery syndrome: a systematic review. Pain Physician. 2009; 12(2): 379-97[PubMed]
  • 7. Shamliyan TA, Staal JB, Goldmann D, Sands-Lincoln M. Epidural steroid injections for radicular lumbosacral pain: a systematic review. Phys Med Rehabil Clin N Am. 2014; 25(2): 471-89 e1-50[DOI][PubMed]
  • 8. FDA Drug Safety Communication: FDA requires label changes to warn of rare but serious neurologic problems after epidural corticosteroid injections for pain. 2014;
  • 9. Long DM. Failed back surgery syndrome. Neurosurg Clin N Am. 1991; 2(4): 899-919[PubMed]
  • 10. Chaparro LE, Furlan AD, Deshpande A, Mailis-Gagnon A, Atlas S, Turk DC. Opioids compared with placebo or other treatments for chronic low back pain: an update of the Cochrane Review. Spine (Phila Pa 1976). 2014; 39(7): 556-63[DOI][PubMed]
  • 11. Meissner W, Schmidt U, Hartmann M, Kath R, Reinhart K. Oral naloxone reverses opioid-associated constipation. Pain. 2000; 84(1): 105-9[PubMed]
  • 12. Brock C, Olesen SS, Olesen AE, Frokjaer JB, Andresen T, Drewes AM. Opioid-induced bowel dysfunction: pathophysiology and management. Drugs. 2012; 72(14): 1847-65[DOI][PubMed]
  • 13. Meissner W, Leyendecker P, Mueller-Lissner S, Nadstawek J, Hopp M, Ruckes C, et al. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain. 2009; 13(1): 56-64[DOI][PubMed]
  • 14. Riley J, Eisenberg E, Muller-Schwefe G, Drewes AM, Arendt-Nielsen L. Oxycodone: a review of its use in the management of pain. Curr Med Res Opin. 2008; 24(1): 175-92[DOI][PubMed]
  • 15. Smith K, Hopp M, Mundin G, Bond S, Bailey P, Woodward J, et al. Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers. Expert Opin Investig Drugs. 2011; 20(4): 427-39[DOI][PubMed]
  • 16. Leppert W. Oxycodone/naloxone in the management of patients with pain and opioid-induced bowel dysfunction. Curr Drug Targets. 2014; 15(1): 124-35[PubMed]
  • 17. Lowenstein O, Leyendecker P, Hopp M, Schutter U, Rogers PD, Uhl R, et al. Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial. Expert Opin Pharmacother. 2009; 10(4): 531-43[DOI][PubMed]
  • 18. Ahmedzai SH, Nauck F, Bar-Sela G, Bosse B, Leyendecker P, Hopp M. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. Palliat Med. 2012; 26(1): 50-60[DOI][PubMed]
  • 19. Mercadante S, Ferrera P, Adile C. High doses of oxycodone-naloxone combination may provide poor analgesia. Support Care Cancer. 2011; 19(9): 1471-2[DOI][PubMed]
  • 20. Chan CW, Peng P. Failed back surgery syndrome. Pain Med. 2011; 12(4): 577-606[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments